A Neradová, F Stam, J G van den Berg, W A Bax. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antirheumatic Agents/adverse effectsAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyEtanerceptHumansImmunoglobulin G/adverse effectsImmunoglobulin G/therapeutic useLupus Erythematosus, Systemic/chemically inducedLupus Erythematosus, Systemic/diagnosisLupus Nephritis/chemically inducedLupus Nephritis/diagnosisMaleMiddle AgedReceptors, Tumor Necrosis Factor/therapeutic useTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances： See more » Antirheumatic AgentsImmunoglobulin GReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaEtanercept
Year: 2009 PMID： 19433471 DOI： 10.1177/0961203308100560
Source DB: PubMed Journal: Lupus ISSN： 0961-2033 Impact factor: 2.911